EUVIMEDEUVIMED entdecken
Crossref

CD34+ Orbital Fibroblasts Contribute to the Pathogenesis of Thyroid Eye Disease via miR-182-5p

Baiguang Yu, Yi Wang, Jun Jin, Jin Liu, Yazhuo Huang, Yang Wang, Chenfang Zhu, Yinwei Li, Bin Li iD, Jing Sun, Dan Li, Sijie Fang iD und 1 weitere

The Journal of Clinical Endocrinology & Metabolism · 07.08.2025 · 110 (9) · 2631-2644

DOI: 10.1210/clinem/dgae876 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 18.12.2024. Verfasst von Baiguang Yu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, and Center for Basic …. Hauptthemen laut MEDLINE: MicroRNAs, Graves Ophthalmopathy, Fibroblasts, Antigens, CD34. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 67 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Research Grant of the Shanghai Science and Technology Committee, Shanghai Key Clinical Specialty, Shanghai Eye Disease Research Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

CD34+ orbital fibroblasts (OFs) play a pathogenic role in thyroid eye disease (TED). Several micro (mi)RNAs have been shown to promote TED progression.

Objective

This study aims to explore the regulatory effects of miRNAs on CD34+ OFs and to find potential therapeutic targets.

Methods

In this case-control study, orbital connective tissues (OCTs) and OFs were obtained from 25 TED patients and 24 healthy donors. MiRNA-seq was performed to examine differential expression of miRNAs in OCTs, and miR-182-5p was selected for subsequent experiments. MiR-182-5p was detected both in CD34+ and CD34− OFs. The upstream regulators of miR-182-5p were studied. Downstream targets of miR-182-5p were analyzed. The functionality of miR-182-5p in CD34+ OFs was evaluated.

Results

MiR-182-5p was highly expressed in TED OCTs and their derived CD34+ OFs. TED OCTs displayed increased expression of interleukin (IL)-6, IL-17A, CD34, and phosphorylated STAT3 at Ser727 and Tyr705. Activation of IL-6/STAT3 signaling promoted the expression of miR-182-5p in CD34+ OFs. MiR-182-5p enhanced wound repair ability, proliferation, and RANTES expression while inhibiting apoptosis in CD34+ OFs. CD34+ OFs transfected with miR-182-5p were susceptible to TGF-β-initiated myofibroblast differentiation. Luciferase reporter and pull-down assays revealed Smad7 as the downstream target of miR-182-5p, which modulated the proliferation, migration, fibrosis, and apoptosis of CD34+ OFs.

Conclusion

The IL-6/STAT3/miR-182-5p pathway led to activation of CD34+ OFs. MiR-182-5p promoted the proliferation, migration, fibrosis, and anti-apoptosis of CD34+ OFs via targeting Smad7. Our findings suggest that miR-182-5p may potentially serve as a therapeutic target for TED.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsGraves OphthalmopathyFibroblastsAntigens, CD34OrbitHumansMaleFemaleCase-Control StudiesMiddle AgedAdultCell ProliferationCells, CulturedSignal TransductionSTAT3 Transcription FactorApoptosis

Stichwörter der Autor:innen

interleukin-6microRNAorbital fibroblastsmad7thyroid eye disease

Substanzen

MicroRNAsAntigens, CD34Mirn182 microRNA, humanSTAT3 protein, humanSTAT3 Transcription Factor

Autor:innen und Institutionen

  • Department of Ophthalmology, Shanghai Ninth People's Hospital, Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, and Center for Basic Medical Research and Innovation in Visual System Diseases of Ministry…
  • Center for Immune-Related Diseases at Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine, Shanghai 200023, China.
  • Department of Immunology and Microbiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200023, China.
  • Chinese Consortium for Thyroid Eye Disease (CCTED), Shanghai 200001, China.
  • Department of General Surgery, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200023, China.

ORCID-Profile: Bin Li, Sijie Fang, Huifang Zhou

Förderung

  • National Natural Science Foundation of China
  • Research Grant of the Shanghai Science and Technology Committee
  • Shanghai Key Clinical Specialty, Shanghai Eye Disease Research Center
  • Clinical Acceleration Program of Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
  • the Sample Database Project of Shanghai Ninth People's Hospital
  • and the Joint Innovation Team for Young Physicians of Shanghai Ninth People's Hospital

Zitieren

APA

Yu, B., Wang, Y., Jin, J., Liu, J., Huang, Y., Wang, Y., Zhu, C., Li, Y., Li, B., Sun, J., Li, D., Fang, S., & Zhou, H. (2025). CD34+ Orbital Fibroblasts Contribute to the Pathogenesis of Thyroid Eye Disease via miR-182-5p. The Journal of Clinical Endocrinology & Metabolism, 110(9), 2631-2644. https://doi.org/10.1210/clinem/dgae876

Vancouver

Yu B, Wang Y, Jin J, Liu J, Huang Y, Wang Y, et al. CD34+ Orbital Fibroblasts Contribute to the Pathogenesis of Thyroid Eye Disease via miR-182-5p. The Journal of Clinical Endocrinology & Metabolism. 2025;110(9):2631-2644. doi:10.1210/clinem/dgae876

BibTeX
@article{Yu2025,
  author = {Yu, Baiguang and Wang, Yi and Jin, Jun and Liu, Jin and Huang, Yazhuo and Wang, Yang and Zhu, Chenfang and Li, Yinwei and Li, Bin and Sun, Jing and Li, Dan and Fang, Sijie and Zhou, Huifang},
  title = {CD34+ Orbital Fibroblasts Contribute to the Pathogenesis of Thyroid Eye Disease via miR-182-5p},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  volume = {110},
  number = {9},
  pages = {2631--2644},
  doi = {10.1210/clinem/dgae876}
}
Kostenlos starten →